Halicyclamine A, a marine spongean alkaloid as a lead for anti-tuberculosis agent
Masayoshi Arai(The University of Osaka), Motomasa Kobayashi(The University of Osaka), Catherine Vilchèze(Albert Einstein College of Medicine), Mari Sobou(The University of Osaka), Anthony D. Baughn(Albert Einstein College of Medicine), Patamaporn Pruksakorn(The University of Osaka), Hiroyuki Hashizume(Otsuka (Japan)), Shunsuke Ishida(The University of Osaka), Makoto Matsumoto(Tottori University Hospital), William R. Jacobs(Albert Einstein College of Medicine)
Cited by 75
Related Papers
A Toll-like receptor recognizes bacterial DNA
|Nature|2000|6.4k
HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY
|The Lancet|1986|2.4k
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
|Immunity|1998|2k
Essential role of Stat6 in IL-4 signalling
|Nature|1996|1.6k
Targeted disruption of the mouse <i>Stat3</i> gene leads to early embryonic lethality
|Proceedings of the National Academy of Sciences|1997|1.3k